The global hemostats market, valued at US$ 2,744.28 million in 2023, is poised to experience significant growth over the next decade, with projections indicating a market value of US$ 4,568.90 million ...

The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...

The global hemostasis products market is poised for significant growth in the coming decade, according to the latest market projections. Valued at USD 1.58 billion in 2023, the market is anticipated ...

About United Health Products -- UHP has developed and patented a Neutralized Regenerated Cellulose hemostatic agent. CelluSTAT Hemostatic Gauze is an all-natural product designed to control mild ...

Chandigarh [India], February 28: SeraSeal™, the world's first and only primary hemostatic agent, has been approved for use in trauma and emergency bleed management under the Nammai Kaakkum 48 ...